Eli Lilly And Stock Price on December 31, 2022
LLY Stock | USD 777.77 11.09 1.45% |
Below is the normalized historical share price chart for Eli Lilly and extending back to June 01, 1972. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Eli Lilly stands at 777.77, as last reported on the 7th of May, with the highest price reaching 779.09 and the lowest price hitting 762.11 during the day.
If you're considering investing in Eli Stock, it is important to understand the factors that can impact its price. We consider Eli Lilly very steady. Eli Lilly secures Sharpe Ratio (or Efficiency) of 0.0714, which denotes the company had a 0.0714% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Eli Lilly and, which you can use to evaluate the volatility of the firm. Please confirm Eli Lilly's Coefficient Of Variation of 765.54, downside deviation of 1.69, and Mean Deviation of 1.39 to check if the risk estimate we provide is consistent with the expected return of 0.13%.
At this time, Eli Lilly's Liabilities And Stockholders Equity is fairly stable compared to the past year. Stock Based Compensation To Revenue is likely to rise to 0.02 in 2024, whereas Total Stockholder Equity is likely to drop slightly above 9 B in 2024. . At this time, Eli Lilly's Price To Sales Ratio is fairly stable compared to the past year. Price Earnings Ratio is likely to rise to 105.14 in 2024, despite the fact that Price Earnings To Growth Ratio is likely to grow to (5.94). Eli Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 13th of January 1978 | 200 Day MA 633.4504 | 50 Day MA 760.8968 | Beta 0.367 |
Eli |
Sharpe Ratio = 0.0714
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | LLY | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
1.82 actual daily | 16 84% of assets are more volatile |
Expected Return
0.13 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Eli Lilly is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Eli Lilly by adding it to a well-diversified portfolio.
Price Book 66.3424 | Enterprise Value Ebitda 86.0117 | Price Sales 20.9422 | Shares Float 898.1 M | Dividend Share 4.69 |
Eli Lilly Valuation on December 31, 2022
It is possible to determine the worth of Eli Lilly on a given historical date. On December 31, 2022 Eli was worth 367.49 at the beginning of the trading date compared to the closed value of 361.63. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Eli Lilly stock. Still, in general, we apply an absolute valuation method to find Eli Lilly's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Eli Lilly where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Eli Lilly's related companies.
Open | High | Low | Close | Volume | |
368.10 | 370.95 | 362.80 | 362.80 | 1,077,900 | |
12/30/2022 | 367.49 | 367.95 | 361.63 | 361.63 | 1,388,000 |
366.26 | 369.00 | 360.79 | 360.79 | 2,006,700 |
Backtest Eli Lilly | | | Eli Lilly History | | | Eli Lilly Valuation | Previous | Next |
Eli Lilly Trading Date Momentum on December 31, 2022
On January 03 2023 Eli Lilly and was traded for 360.79 at the closing time. Highest Eli Lilly's price during the trading hours was 369.00 and the lowest price during the day was 360.79 . The net volume was 2 M. The overall trading history on the 3rd of January contributed to the next trading period price depreciation. The trading delta at closing time to the next next day price was 0.23% . The overall trading delta to current price is 0.66% . |
Eli Lilly Fundamentals Correlations and Trends
By evaluating Eli Lilly's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Eli Lilly's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Eli financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Eli Lilly Stock history
Eli Lilly investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Eli is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Eli Lilly will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Eli Lilly stock prices may prove useful in developing a viable investing in Eli Lilly
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 903.3 M | 868.4 M | |
Net Income Applicable To Common Shares | 7.2 B | 4 B |
Eli Lilly Stock Technical Analysis
Eli Lilly technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Eli Lilly Period Price Range
Low | December 30, 2022
| High |
367.49 | 361.63 |
Eli Lilly May 7, 2024 Market Strength
Market strength indicators help investors to evaluate how Eli Lilly stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eli Lilly shares will generate the highest return on investment. By undertsting and applying Eli Lilly stock market strength indicators, traders can identify Eli Lilly and entry and exit signals to maximize returns
Accumulation Distribution | 23840.63 | |||
Daily Balance Of Power | (0.93) | |||
Rate Of Daily Change | 0.98 | |||
Day Median Price | 364.79 | |||
Day Typical Price | 363.74 | |||
Price Action Indicator | (6.09) | |||
Period Momentum Indicator | 416.14 | |||
Relative Strength Index | 54.74 |
Eli Lilly Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Eli Lilly's price direction in advance. Along with the technical and fundamental analysis of Eli Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Eli to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0884 | |||
Jensen Alpha | 0.2274 | |||
Total Risk Alpha | 0.0406 | |||
Sortino Ratio | 0.1049 | |||
Treynor Ratio | 1.05 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Eli Lilly and. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Complementary Tools for Eli Stock analysis
When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
Is Eli Lilly's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eli Lilly. If investors know Eli will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eli Lilly listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.664 | Dividend Share 4.69 | Earnings Share 6.77 | Revenue Per Share 39.919 | Quarterly Revenue Growth 0.26 |
The market value of Eli Lilly is measured differently than its book value, which is the value of Eli that is recorded on the company's balance sheet. Investors also form their own opinion of Eli Lilly's value that differs from its market value or its book value, called intrinsic value, which is Eli Lilly's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eli Lilly's market value can be influenced by many factors that don't directly affect Eli Lilly's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eli Lilly's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eli Lilly is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eli Lilly's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.